RP1 and nivolumab combination achieved a 32.9% objective response rate and 15.0% complete response rate in advanced melanoma ...
This discussion examines the key considerations oncologists weigh when choosing between chemotherapy alone or chemotherapy ...
PD-1 checkpoint proteins on T cells (blue) can bind to two different receptors: PD-L1 and PD-L2. There are many ways to climb a mountain. This saying especially rings true in cancer research, where ...
Registry of Genetic Alterations of Taiwan Non–Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521 Overall, 142 ...
When many cancers advance, spread and reoccur, checkpoint inhibitors can help keep difficult tumors at bay. These antibody-based immunotherapies can restore the body’s ability to recognize and ...
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Merck & Co.’s cancer immunotherapy Keytruda is one of ...
The U.S. price of the first PD-1 inhibitor developed in China has been revealed. Coherus BioSciences has established a wholesale acquisition cost for Loqtorzi at $8,892.03 per single-use vial, the ...
Aggressive forecasts for the GLP-1 obesity market have caused no small amount of anxiety among insurers, employers and others nervous about managing this gathering tsunami. The arrival of this wave in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback